$3.98
0.102.58%
At close: -
$3.93
-0.05-1.26%
After Hours: Jan 3, 5:03 PM EDT
Comments
Loading...
Citius Pharmaceuticals (NASDAQ:CTXR) Stock, Earnings Estimates, EPS, And Revenue
Citius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS Estimate
$-1.250
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Citius Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Citius Pharmaceuticals (CTXR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-12-27 | $-1.72 | $-2.00 | 14.0 % |
| Q3 | 2024-08-12 | $-1.50 | $-1.50 | 0.00 % |
| Q2 | 2024-05-14 | $-1.25 | $-1.25 | 0.00 % |
| Q2 | 2023-05-12 | $-1.75 | $-0.75 | -133.3 % |
Citius Pharmaceuticals (CTXR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?
Citius Pharmaceuticals (CTXR) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on December 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Citius Pharmaceuticals (NASDAQ:CTXR)?
The Actual EPS was $-1.72, which beat the estimate of $-2.00.
What were Citius Pharmaceuticals’s (NASDAQ:CTXR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.